World's Best Scientists 2026 revealed!
Jean-Michel Molina

Jean-Michel Molina

D-Index & Metrics

Medicine

D-Index
98
Citations
41712
World Ranking
8836
National Ranking
267

Overview

Jean-Michel Molina is affiliated with Université Paris Cité in France. Their research primarily focuses on infectious diseases and HIV/AIDS, with substantial contributions to the fields of medicine, immunology, and microbiology.

The scientist's recent publications include:

  • No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection, 2020, Médecine et Maladies Infectieuses
  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults, 2022, JAMA
  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults, 2020, JAMA
  • Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial, 2020, The Lancet
  • Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection, 2022, New England Journal of Medicine

Jean-Michel Molina frequently collaborates with several researchers, including:

  • Constance Delaugerre
  • Christine Katlama
  • Nathalie De Castro
  • Lambert Assoumou
  • Laurence Meyer

Their work has appeared predominantly in the following venues:

  • Clinical Infectious Diseases
  • Open Forum Infectious Diseases
  • Médecine et Maladies Infectieuses Formation
  • AIDS
  • Journal of Antimicrobial Chemotherapy

The scientist's research fields include:

  • Medicine
  • Immunology and Microbiology

Within these broader fields, subfields of study are:

  • Infectious Diseases
  • Epidemiology
  • Virology
  • Emergency Medicine
  • Surgery

Core research topics include:

  • HIV/AIDS Research and Interventions
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • HIV-related health complications and treatments
  • HIV, Drug Use, Sexual Risk
  • Pneumocystis jirovecii pneumonia detection and treatment
  • COVID-19 Clinical Research Studies

Best Publications

  • Initiation of antiretroviral therapy in early asymptomatic HIV infection

    Sean Emery;Shweta Sharma;Gerd Fätkenheuer;Josep M. Llibre

  • HLA-B*5701 Screening for Hypersensitivity to Abacavir

    Simon Mallal;Elizabeth Phillips;Giampiero Carosi;Jean-Michel Molina

  • On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection

    Abstr Act;C. Capitant;B. Spire;G. Pialoux

  • Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

    Paul E Sax;David Wohl;Michael T Yin;Frank Post

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel

    Michael S. Saag;Constance A. Benson;Rajesh T. Gandhi;Jennifer F. Hoy

  • Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

    Jean-Michel Molina;Jaime Andrade-Villanueva;Juan Echevarria;Ploenchan Chetchotisakd

  • Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

    Bonaventura Clotet;Nicholas Bellos;Jean Michel Molina;David Cooper

  • Hematopoietic growth factors. Biology and clinical applications.

    J E Groopman;J M Molina;D T Scadden

  • Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): A phase 3 randomised double-blind active-controlled trial

    Jean Michel Molina;Pedro Cahn;Beatriz Grinsztejn;Adriano Lazzarin

  • Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study

    Jean-Michel Molina;Jean-Michel Molina;Isabelle Charreau;Bruno Spire;Laurent Cotte

  • Tenofovir-Related Nephrotoxicity in Human Immunodeficiency Virus-Infected Patients: Three Cases of Renal Failure, Fanconi Syndrome, and Nephrogenic Diabetes Insipidus

    Alexandre Karras;Matthieu Lafaurie;André Furco;Anne Bourgarit

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.

    Michael S. Saag;Rajesh T. Gandhi;Jennifer F. Hoy;Raphael J. Landovitz

  • Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

    Edwin DeJesus;Jürgen K. Rockstroh;Keith Henry;Jean Michel Molina

  • Enhanced T cell recovery in HIV-1–infected adults through IL-7 treatment

    Yves Levy;Christine Lacabaratz;Laurence Weiss;Jean-Paul Viard

  • Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.

    Kenneth H Mayer;Kenneth H Mayer;Jean-Michel Molina;Melanie A Thompson;Peter L Anderson

  • Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.

    Jean-Michel Molina;Isabelle Charreau;Christian Chidiac;Gilles Pialoux

  • Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

    Antonella Castagna;Franco Maggiolo;Giovanni Penco;David Wright

  • Prognostic Factors and Outcome of Human Herpesvirus 8–Associated Primary Effusion Lymphoma in Patients With AIDS

    Emmanuelle Boulanger;Laurence Gérard;Jean Gabarre;Jean-Michel Molina

  • Fumagillin Treatment of Intestinal Microsporidiosis

    Jean-Michel Molina;Muriel Tourneur;Claudine Sarfati;Sylvie Chevret

  • Once-daily atazanavir/ritonavir compared with twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 96-week efficacy and safety results of the CASTLE study.

    Jean-Michel Molina;Jaime Andrade-Villanueva;Juan Echevarria;Ploenchan Chetchotisakd

Frequent Co-Authors

Constance Delaugerre
Constance Delaugerre Université Paris Cité
Gilles Pialoux
Gilles Pialoux Tenon Hospital
Francis Derouin
Francis Derouin Université Paris Cité
Geneviève Chêne
Geneviève Chêne University of Bordeaux
Laurence Meyer
Laurence Meyer University of Paris-Saclay
Christine Katlama
Christine Katlama Sorbonne University
Edwin DeJesus
Edwin DeJesus Hanover University of Applied Sciences and Arts
Philippe Morlat
Philippe Morlat University of Bordeaux
Chloe Orkin
Chloe Orkin Queen Mary University of London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to diverse online degrees and allied health pathways. Students interested in holistic care often choose an online degree in nutrition. This program blends science and health, preparing graduates for roles in dietetics, wellness, and public health.

For those seeking healthcare leadership positions, a cahme accredited online mha program ensures training in administration and management from a reputable source. Nurses looking to advance can benefit from online rn to bsn programs without clinical requirements, offering flexibility for busy professionals.

For advanced nursing leaders, the shortest dnp program online helps experienced nurses reach the highest level of practice efficiently. Each pathway is designed to be flexible, with accredited options, making them accessible even for those balancing work and study.

Best Scientists Citing Jean-Michel Molina

Trending Scientists

Recently Published Articles